We would love to hear your thoughts about our site and services, please take our survey here.
Wildbunch,
To be Frank, i cannot class IMM or many other biotechs as 'investments' ... We do of course put our Money in but i prefer to call them 'punts' rather than investments as they are very High risk / volatile stocks .
Anyway, i do agree that the risk/reward ratio seems very attractive at this Time ..and some People may be awaiting further confirmation on the Avion commitment before 'investing' in IMM
Que sera sera
Wildbunch,
I am far from being faultless but i was not trying to calculate ROI ,but trying to show what effect dilution has had in the Last few years .. but miscalculated :-)
Anyway it's good to be wrong , and WE are Always learning ...
Would it be fair to Say that the market values IMM at 5/6 Times it's cash ?
Ontarget,
Cauldstream7 could'nt see any logical reason...
The simple fact IS that he paid 48.5p in 2013 when IMM had a market cap of roughly £40 million ... they are now 5 Times more shares in issue, so if WE just basically divide £40 million by 5 WE get £8 million ....
Imm has a Mcap of over £7 million so WE are basically AT similar levels as when he bought in...
If you get my drift
Https://www.lse.co.uk/rns/preliminary-results-mzvvz4i517x3o2o.html
History lesson
Wildbunch,
A punter rarely goes to any AGM etc , but as you correctly point out , you have put a sizeable informed punt on IMM AT under 2p so you have really no reasonable to moan or to filter anyone :-)
Your situation IS very different to the majority of IMM shareholders .
Best of Luck to you ..
Wildbunch,
I have been filtered / insulted etc by many over the years yet i have only filtered one person for consistent personal Attacks .
The major drawback on these boards IS that the majority of posters only want to read 'positive' conjectures and want to brush under the carpet any 'negatives' ...
Whilst being reasonable and fair , one Can only Say that in the Last five years , shareholders have been appalingly let Down by IMM ...
management Performance History / credibility should be on the Top of any investors check-list before investing but IS rarely verified by us PI.
The past IS the past, the future IS not ours to see, Que sera, sera
The voucher is the cherry on the cake, After getting market approval. There is a long Road to go before getting a voucher so it's very premature to be talking about it , even though it's a Great incentive .
Getting the orphan drug designation will be a very important milestone as it will accelerate partnership discussions.
Bottom drawer investment for me ..